Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga Insights

TherapeuticsMD: Q4 Earnings Insights


TherapeuticsMD (NASDAQ:TXMD) reported its Q4 earnings results on Thursday, March 10, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.


TherapeuticsMD missed estimated earnings by 12.5%, reporting an EPS of $-0.09 versus an estimate of $-0.08.

Revenue was down $3.90 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 4.67% drop in the share price the next day.

Here's a look at TherapeuticsMD's past performance:


Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.10 -0.11 -0.12 -0.10
EPS Actual -0.11 -0.11 -0.11 -0.15
Revenue Estimate 25.87M 22.11M 19.77M 21.89M
Revenue Actual 25.41M 23.00M 19.87M 22.58M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.